In particular, interleukin-6 (IL-6) and its intracellular signaling molecule signal transducer and activator of transcription 3 (STAT3) seem to play a vital role in bridging chronic inflammation to HCC progression [9, 12]. Here, IL6 is linked to hepatocellular carcinoma.